ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,848
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
A phase IIa study to assess the safety, efficacy, and pharmacokinetics of subcutaneously administered pegcetacoplan (APL-2) in subjects with PNH
Author(s):
Publication date:
2018
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Dermal Microdialysis in Pharmacokinetics
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,848
Impact of baseline characteristics on geographic atrophy progression in the FILLY trial evaluating the complement C3 inhibitor pegcetacoplan
Authors:
NC Steinle
,
I PEARCE
,
J. Monès
…
Injection-site reactions at week 48 in the randomized phase 3 PEGASUS trial of pegcetacoplan compared with eculizumab for individuals with paroxysmal nocturnal hemoglobinuria
Authors:
V. SHARMA
,
I. Weitz
,
J Koprivnikar
P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH-RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBIN AT OR ABOVE 10 G/DL
Authors:
J Panse
,
N DAGUINDAU
,
S Okuyama
…
See all similar
Cited by
1
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria
Authors:
Raymond S.M. Wong
See all cited by